Immune checkpoint inhibitors in bladder cancer: from mechanistic insights to emerging combination frontlines

Scritto il 05/03/2026
da Mohammad Mahdi Ajalli

No abstract

Clin Exp Med. 2026 Mar 5. doi: 10.1007/s10238-026-02098-3. Online ahead of print.

NO ABSTRACT

PMID:41784671 | DOI:10.1007/s10238-026-02098-3